David L Mahoney - Net Worth and Insider Trading

David L Mahoney Net Worth

The estimated net worth of David L Mahoney is at least $76 Million dollars as of 2024-11-13. David L Mahoney is the Director of Corcept Therapeutics Inc and owns about 1,233,375 shares of Corcept Therapeutics Inc (CORT) stock worth over $71 Million. David L Mahoney is the Director of Gen Digital Inc and owns about 137,840 shares of Gen Digital Inc (GEN) stock worth over $4 Million. David L Mahoney is also the Director of Adamas Pharmaceuticals Inc and owns about 10,674 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $87,740. Details can be seen in David L Mahoney's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David L Mahoney has not made any transactions after 2023-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David L Mahoney

To

David L Mahoney Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David L Mahoney owns 3 companies in total, including Adamas Pharmaceuticals Inc (ADMS) , Corcept Therapeutics Inc (CORT) , and Gen Digital Inc (GEN) .

Click here to see the complete history of David L Mahoney’s form 4 insider trades.

Insider Ownership Summary of David L Mahoney

Ticker Comapny Transaction Date Type of Owner
ADMS Adamas Pharmaceuticals Inc 2020-06-03 director
CORT Corcept Therapeutics Inc 2023-08-14 director
GEN Gen Digital Inc 2014-12-15 director

David L Mahoney Latest Holdings Summary

David L Mahoney currently owns a total of 3 stocks. Among these stocks, David L Mahoney owns 1,233,375 shares of Corcept Therapeutics Inc (CORT) as of August 14, 2023, with a value of $71 Million and a weighting of 94.31%. David L Mahoney owns 137,840 shares of Gen Digital Inc (GEN) as of December 15, 2014, with a value of $4 Million and a weighting of 5.57%. David L Mahoney also owns 10,674 shares of Adamas Pharmaceuticals Inc (ADMS) as of April 9, 2014, with a value of $87,740 and a weighting of 0.12%.

Latest Holdings of David L Mahoney

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CORT Corcept Therapeutics Inc 2023-08-14 1,233,375 57.79 71,276,741
GEN Gen Digital Inc 2014-12-15 137,840 30.54 4,209,634
ADMS Adamas Pharmaceuticals Inc 2014-04-09 10,674 8.22 87,740

Holding Weightings of David L Mahoney


David L Mahoney Form 4 Trading Tracker

According to the SEC Form 4 filings, David L Mahoney has made a total of 1 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Corcept Therapeutics Inc is the sale of 25,000 shares on August 14, 2023, which brought David L Mahoney around $773,750.

According to the SEC Form 4 filings, David L Mahoney has made a total of 0 transactions in Gen Digital Inc (GEN) over the past 5 years. The most-recent trade in Gen Digital Inc is the sale of 12,000 shares on December 15, 2014, which brought David L Mahoney around $303,960.

According to the SEC Form 4 filings, David L Mahoney has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 0 shares on April 9, 2014, which brought David L Mahoney around $0.

Insider Trading History of David L Mahoney

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David L Mahoney Trading Performance

GuruFocus tracks the stock performance after each of David L Mahoney's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David L Mahoney is 6.73%. GuruFocus also compares David L Mahoney's trading performance to market benchmark return within the same time period. The performance of stocks bought by David L Mahoney within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David L Mahoney's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David L Mahoney

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.44 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 10.71 LIMIT LIMIT LIMIT LIMIT LIMIT

David L Mahoney Ownership Network

Ownership Network List of David L Mahoney

No Data

Ownership Network Relation of David L Mahoney

Insider Network Chart

David L Mahoney Owned Company Details

What does Adamas Pharmaceuticals Inc do?

Who are the key executives at Adamas Pharmaceuticals Inc?

David L Mahoney is the director of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .

Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adamas Pharmaceuticals Inc Insider Transactions

No Available Data

David L Mahoney Mailing Address

Above is the net worth, insider trading, and ownership report for David L Mahoney. You might contact David L Mahoney via mailing address: Symantec Corporation, 20330 Stevens Creek Blvd., Cupertino Ca 95014.